Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg / day) in a B.I.D. regimen-Reference-Cited by-同舟云学术

Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg / day) in a B.I.D. regimen

Published:2002-03 Issue:2 Volume:11 Page:104-113
ISSN:1059-1311
Container-title:Seizure
language:en
Short-container-title:Seizure

Author:

Jones M.W,Blume W.T,Guberman A,Lee M.A,Pillay N,Weaver D.F,Veloso F,Holdich T.A.H

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference8 articles.

1. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro;Palmer;Archives Internationales de Pharmacodynamie et de Therapie,1992

2. Mutual pharmacokinetic interactions between remacemide and carbamazepine and phenytoin but not sodium valproate in epileptic patients;Leach;Epilepsia,1994

3. Mutual interaction between remacemide hydrochloride and carbamazepine: two drugs with active metabolites;Leach;Epilepsia,1996

4. Mutual interaction between remacemide hydrochloride and phenytoin;Leach;Epilepsy Research,1997

5. Economic Control of Quality of Manufactured Product;Shewhart,1931

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting NMDA Receptor Complex in Management of Epilepsy;Pharmaceuticals;2022-10-21

2. Targeting NMDA Receptors in Epilepsy;Pathologies of Calcium Channels;2013-11-09

3. The NMDA receptor complex as a therapeutic target in epilepsy: a review;Epilepsy & Behavior;2011-12

4. Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis;Epilepsia;2011-01

5. Placebo responses in randomized trials of antiepileptic drugs;Epilepsy & Behavior;2010-01